|
1
|
Gryfe R, Swallow C, Bapat B, Redston M,
Gallinger S and Couture J: Molecular biology of colorectal cancer.
Curr Probl Cancer. 21:233–300. 1997. View Article : Google Scholar
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wittekind C and Neid M: Cancer invasion
and metastasis. Oncology. 69(Suppl 1): S14–S16. 2005. View Article : Google Scholar
|
|
4
|
Fidler IJ, Yano S, Zhang RD, Fujimaki T
and Bucana CD: The seed and soil hypothesis: Vascularisation and
brain metastases. Lancet Oncol. 3:53–57. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rudmik LR and Magliocco AM: Molecular
mechanisms of hepatic metastasis in colorectal cancer. J Surg
Oncol. 92:347–359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takayama T, Miyanishi K, Hayashi T, Sato Y
and Niitsu Y: Colorectal cancer: Genetics of development and
metastasis. J Gastroenterol. 41:185–192. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP and Chen CZ: Micromanagers of
gene expression: The potentially widespread influence of metazoan
microRNAs. Nat Rev Genet. 5:396–400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S, et al: The nuclear RNase III
Drosha initiates microRNA processing. Nature. 425:415–419. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lund E, Güttinger S, Calado A, Dahlberg JE
and Kutay U: Nuclear export of microRNA precursors. Science.
303:95–98. 2004. View Article : Google Scholar
|
|
12
|
Dai X, Chiang Y, Wang Z, Song Y, Lu C, Gao
P and Xu H: Expression levels of microRNA-375 in colorectal
carcinoma. Mol Med Rep. 5:1299–1304. 2012.PubMed/NCBI
|
|
13
|
Wang S, Wang L, Bayaxi N, Li J, Verhaegh
W, Janevski A, Varadan V, Ren Y, Merkle D, Meng X, et al: A
microRNA panel to discriminate carcinomas from high-grade
intraepithelial neoplasms in colonoscopy biopsy tissue. Gut.
62:280–289. 2013. View Article : Google Scholar
|
|
14
|
Xu L, Li M, Wang M, Yan D, Feng G and An
G: The expression of microRNA-375 in plasma and tissue is matched
in human colorectal cancer. BMC Cancer. 14:7142014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Tang Q, Li M, Jiang S and Wang X:
MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Biochem Biophys Res Commun. 444:199–204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar :
|
|
17
|
Le XF, Merchant O, Bast RC and Calin GA:
The roles of microRNAs in the cancer invasion-metastasis cascade.
Cancer Microenviron. 3:137–147. 2010. View Article : Google Scholar
|
|
18
|
Liu M and Chen H: The role of microRNAs in
colorectal cancer. J Genet Genomics. 37:347–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
El Ouaamari A, Baroukh N, Martens GA,
Lebrun P, Pipeleers D and van Obberghen E: miR-375 targets
3′-phosphoinositide-dependent protein kinase-1 and regulates
glucose-induced biological responses in pancreatic beta-cells.
Diabetes. 57:2708–2717. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poy MN, Hausser J, Trajkovski M, Braun M,
Collins S, Rorsman P, Zavolan M and Stoffel M: miR-375 maintains
normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci
USA. 106:5813–5818. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y,
Yao H, Liu X, Ke Y, Si J, et al: MiR-375 frequently downregulated
in gastric cancer inhibits cell proliferation by targeting JAK2.
Cell Res. 20:784–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nishikawa E, Osada H, Okazaki Y, Arima C,
Tomida S, Tatematsu Y, Taguchi A, Shimada Y, Yanagisawa K, Yatabe
Y, et al: miR-375 is activated by ASH1 and inhibits YAP1 in a
lineage-dependent manner in lung cancer. Cancer Res. 71:6165–6173.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Black AR, Black JD and Azizkhan-Clifford
J: Sp1 and krüppel-like factor family of transcription factors in
cell growth regulation and cancer. J Cell Physiol. 188:143–160.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Willoughby JA Sr, Sundar SN, Cheung M, Tin
AS, Modiano J and Firestone GL: Artemisinin blocks prostate cancer
growth and cell cycle progression by disrupting Sp1 interactions
with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting
CDK4 gene expression. J Biol Chem. 284:2203–2213. 2009. View Article : Google Scholar :
|
|
25
|
Wei M, Liu B, Gu Q, Su L, Yu Y and Zhu Z:
Stat6 cooperates with Sp1 in controlling breast cancer cell
proliferation by modulating the expression of
p21Cip1/WAF1 and p27Kip1. Cell Oncol.
36:79–93. 2013. View Article : Google Scholar
|
|
26
|
Chen Y, Huang Y, Huang Y, Xia X, Zhang J,
Zhou Y, Tan Y, He S, Qiang F, Li A, et al: JWA suppresses tumor
angiogenesis via Sp1-activated matrix metalloproteinase-2 and its
prognostic significance in human gastric cancer. Carcinogenesis.
35:442–451. 2014. View Article : Google Scholar
|
|
27
|
Nam EH, Lee Y, Park YK, Lee JW and Kim S:
ZEB2 upregulates integrin α5 expression through cooperation with
Sp1 to induce invasion during epithelial-mesenchymal transition of
human cancer cells. Carcinogenesis. 33:563–571. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hay ED: An overview of
epithelio-mesenchymal transformation. Acta Anat. 154:8–20. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu QC, Gao RY, Wu W and Qin HL:
Epithelial-mesenchymal transition and its role in the pathogenesis
of colorectal cancer. Asian Pac J Cancer Prev. 14:2689–2698. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Said AH, Raufman JP and Xie G: The role of
matrix metalloproteinases in colorectal cancer. Cancers. 6:366–375.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim K, Lu Z and Hay ED: Direct evidence
for a role of beta-catenin/LEF-1 signaling pathway in induction of
EMT. Cell Biol Int. 26:463–476. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakajima S, Doi R, Toyoda E, Tsuji S, Wada
M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, et al: N-cadherin
expression and epithelial-mesenchymal transition in pancreatic
carcinoma. Clin Cancer Res. 10:4125–4133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zavadil J, Cermak L, Soto-Nieves N and
Böttinger EP: Integration of TGF-beta/Smad and Jagged1/Notch
signalling in epithelial-to-mesenchymal transition. EMBO J.
23:1155–1165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Medici D, Hay ED and Olsen BR: Snail and
Slug promote epithelial-mesenchymal transition through
beta-catenin-T-cell factor-4-dependent expression of transforming
growth factor-beta3. Mol Biol Cell. 19:4875–4887. 2008. View Article : Google Scholar : PubMed/NCBI
|
